<DOC>
	<DOCNO>NCT01897051</DOCNO>
	<brief_summary>To reduce portal pressure , recommend medication nonselective beta blocker ( NSBB ) . However , NSBB limitation apply clinically poor response rate compliance . Recent literature support role bacterial translocation mediator splanchnic vasodilatation portal hypertension . This stimulate release pro-inflammatory cytokine activation vasodilator NO result pronounced deterioration baseline hyperdynamic circulatory state . Selective gut decontamination Rifaximin induce inhibition bacterial translocation associate worsen portal hypertension . The investigator hypothesize Rifaximin plus NSBB could result decrease portal pressure cirrhotic patient esophageal varix .</brief_summary>
	<brief_title>Rifaximin Propranolol Combination Therapy Versus Propranolol Monotherapy Cirrhotic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Liver cirrhosis : diagnose base histology unequivocal clinical , sonographic , laboratory finding 19≤age≤75 Hepatic venous pressure gradient &gt; 12 mmHg Informed consent Shock status require vasopressor Active infection , example Spontaneous bacterial peritonitis Acute renal failure patient cause Clinically relevant coronary artery disease ( NYHA functional angina classification III/IV ) , congestive heart failure NYHA III/IV ) , clinically relevant cardiomyopathy , history myocardial infarction past 12 month Poorly control hypertension ( BP 150/100mmHg ) Hepatocellular carcinoma History another primary malignancy ≤ 3years Medical psychological condition would permit subject complete thte study sign inform consent Pregnancy lactation period Serum creatinine ≧ 6mg/dL Involvement conduct study within 30 day Known hypersensitivity Rifaximin propranolol Dysarrhythmia , inappropriate study investigator 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Liver cirrhosis</keyword>
	<keyword>Portal hypertension</keyword>
	<keyword>Hepatic Venous Pressure Gradient</keyword>
	<keyword>Rifaximin</keyword>
</DOC>